Adenocarcinoma of the lung epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The incidence of adenocarcinoma of the lung is approximately 22.1 per 100,000 individuals worldwide. Adenocarcinoma of the lung affects men and women equally. Patients of all age groups may develop adenocarcinoma of the lung. | The incidence of adenocarcinoma of the lung is approximately 22.1 per 100,000 individuals worldwide. Adenocarcinoma of the lung affects men and women equally. Patients of all age groups may develop adenocarcinoma of the lung. | ||
==Epidemiology and Demographics== | |||
===Incidence=== | |||
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | |||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | |||
===Prevalence=== | |||
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | |||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | |||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | |||
===Case-fatality rate/Mortality rate=== | |||
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. | |||
*The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | |||
===Age=== | |||
*Patients of all age groups may develop [disease name]. | |||
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | |||
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age. | |||
*[Chronic disease name] is usually first diagnosed among [age group]. | |||
*[Acute disease name] commonly affects [age group]. | |||
===Race=== | |||
*There is no racial predilection to [disease name]. | |||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | |||
===Gender=== | |||
*[Disease name] affects men and women equally. | |||
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. | |||
===Region=== | |||
*The majority of [disease name] cases are reported in [geographical region]. | |||
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | |||
===Developed Countries=== | |||
===Developing Countries=== | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
Revision as of 19:38, 2 March 2018
|
Adenocarcinoma of the Lung Microchapters |
|
Differentiating Adenocarcinoma of the Lung from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adenocarcinoma of the lung epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Adenocarcinoma of the lung epidemiology and demographics |
|
FDA on Adenocarcinoma of the lung epidemiology and demographics |
|
CDC on Adenocarcinoma of the lung epidemiology and demographics |
|
Adenocarcinoma of the lung epidemiology and demographics in the news |
|
Blogs on Adenocarcinoma of the lung epidemiology and demographics |
|
Risk calculators and risk factors for Adenocarcinoma of the lung epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
The incidence of adenocarcinoma of the lung is approximately 22.1 per 100,000 individuals worldwide. Adenocarcinoma of the lung affects men and women equally. Patients of all age groups may develop adenocarcinoma of the lung.
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
Epidemiology and Demographics
Prevalence
- Adenocarcinoma of the lung is now considered the most common histological subtypes of lung cancer.[1]
- Nearly 40% of lung cancers in the US are adenocarcinoma.
- Among people who have smoked fewer than 100 cigarettes in their lifetimes, adenocarcinoma is the most common form of lung cancer.
- To view more epidemiological information among patients of lung cancer, please click Here.
Incidence
- The age-adjusted incidence of adenocarcinoma of the lung is approximately 22.1 per 100,000 individuals worldwide.[1]
Gender
- Adenocarcinoma of the lung affects men and women equally.[2]
Age
- Patients of all age groups may develop adenocarcinoma of the lung.[2]
Developed Countries
- The incidence of adenocarcinoma of the lung has been increasing in many developed Western nations in the past few decades, where it has become the most common major type of lung cancer in smokers (replacing squamous cell carcinoma of the lung) and in lifelong nonsmokers.[1]
References
- ↑ 1.0 1.1 1.2 Adenocarcinoma of the lung. Wikipedia 2015. https://en.wikipedia.org/wiki/Adenocarcinoma_of_the_lung#Epidemiology
- ↑ 2.0 2.1 Paris C, Clement-Duchene C, Vignaud JM, Gislard A, Stoufflet A, Bertrand O; et al. (2010). "Relationships between lung adenocarcinoma and gender, age, smoking and occupational risk factors: A case-case study". Lung Cancer. 68 (2): 146–53. doi:10.1016/j.lungcan.2009.06.007. PMID 19586681.